FRESENIUS MEDICAL CARE SUMTER HOME
NPI 1376974717
Clinic/Center - End-Stage Renal Disease (ESRD) Treatment in Sumter, SC

NPI Status: Active since December 11, 2013

Contact Information

653 W WESMAK BLVD
SUMTER, SC
ZIP 29150
Phone: (803) 469-2800
Fax: (803) 469-2857

Get Directions Write a Review

  • Organization
  • Clinic/Center
  • End-Stage Renal Disease (ESRD) Treatment
  • CLIA Number: 42D0249047
  • CLIA Cert. Type: Other
  • CLIA Exp. Date: 08-31-2026

About FRESENIUS MEDICAL CARE SUMTER HOME

This page provides the complete NPI Profile along with additional information for Fresenius Medical Care Sumter Home, a provider established in Sumter, South Carolina operating as a Clinic/center, focusing in end-stage renal disease (esrd) treatment . The healthcare provider is registered in the NPI registry with number 1376974717 assigned on December 2013. The practitioner's primary taxonomy code is 261QE0700X. The provider is registered as an organization and their NPI record was last updated 12 years ago. The provider's is doing business as Fresenius Medical Care Sumter Home. The authorized official of this NPI record is Mr. Mark R Fawcett (Treasurer)

NPI
1376974717
Provider Legal Name
BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC.
Other Organization Name
FRESENIUS MEDICAL CARE SUMTER HOME
Other Name Type
Doing Business As (3)
Entity Type
Organization
Location Address
653 W WESMAK BLVD SUMTER, SC 29150
Location Phone
(803) 469-2800
Location Fax
(803) 469-2857
Mailing Address
653 W WESMAK BLVD SUMTER, SC 29150
Mailing Phone
(803) 469-2800
Mailing Fax
(803) 469-2857
Is Sole Proprietor?
No
Is Organization Subpart?
Yes
Enumeration Date
12-11-2013
Last Update Date
01-14-2014
Code Navigator

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinic/Center End-Stage Renal Disease (ESRD) Treatment

Taxonomy Code
261QE0700X
Type
Ambulatory Health Care Facilities
License State
SC

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

MR. MARK R FAWCETT

Authorized Official Title
TREASURER
Authorized Official Phone
(781) 699-9000

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
42D0249047
Facility Type
Other
Certificate Effective Date
September 01, 2024
Certificate Expiration Date
August 31, 2026
Laboratory Director
MATTHEW FLOYD
Certificate Type
Certificate of Waiver
Certificate Type Description
This CLIA certificate is issued to Fresenius Medical Care Sumter Home to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.

Reviews for FRESENIUS MEDICAL CARE SUMTER HOME

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1376974717, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 73. The final step is to find the difference between that total and the next multiple of ten (80 - 73 = 7).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
3
Unchanged
Pos 3
7
Doubled → 14 → 1 + 4
Pos 4
6
Unchanged
Pos 5
9
Doubled → 18 → 1 + 8
Pos 6
7
Unchanged
Pos 7
4
Doubled → 8
Pos 8
7
Unchanged
Pos 9
1
Doubled → 2
Check
7
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 7 → 14 → 5 9 → 18 → 9 4 → 8 1 → 2

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 3 + 1 + 4 + 6 + 1 + 8 + 7 + 8 + 7 + 2 + 24 = 73

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 73 is 80. The difference is the calculated check digit.

80 - 73 = 7
This NPI is valid
The calculated check digit is 7, which matches the last digit of 1376974717.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1376974717, enumerated as an "organization" on December 11, 2013.

The provider is located at 653 W WESMAK BLVD SUMTER, SC 29150 and the phone number is (803) 469-2800.

Clinic/Center with taxonomy code 261QE0700X and a focus in End-Stage Renal Disease (ESRD) Treatment.